238 related articles for article (PubMed ID: 9626343)
1. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.
Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG
Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J
Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
[TBL] [Abstract][Full Text] [Related]
3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
4. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutation analysis of the p53 gene in astrocytoma.
Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.
Platten M; Giordano MJ; Dirven CM; Gutmann DH; Louis DN
Am J Pathol; 1996 Aug; 149(2):621-7. PubMed ID: 8702000
[TBL] [Abstract][Full Text] [Related]
7. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
[TBL] [Abstract][Full Text] [Related]
8. The lack of a role for p53 in astrocytomas in pediatric patients.
Litofsky NS; Hinton D; Raffel C
Neurosurgery; 1994 Jun; 34(6):967-72; discussion 972-3. PubMed ID: 8084407
[TBL] [Abstract][Full Text] [Related]
9. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.
Wimmer K; Eckart M; Meyer-Puttlitz B; Fonatsch C; Pietsch T
J Neuropathol Exp Neurol; 2002 Oct; 61(10):896-902. PubMed ID: 12387455
[TBL] [Abstract][Full Text] [Related]
10. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
[TBL] [Abstract][Full Text] [Related]
11. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
12. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
[TBL] [Abstract][Full Text] [Related]
14. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
16. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
[TBL] [Abstract][Full Text] [Related]
17. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
[TBL] [Abstract][Full Text] [Related]
18. p53 allelic imbalance in astrocytoma detected using fluorescent PCR of microsatellite repeat polymorphisms.
al-Sarraj S; Bridges LR; Cawkwell L; Lewis FA; Quirke P
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):344-51. PubMed ID: 7494603
[TBL] [Abstract][Full Text] [Related]
19. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Finkelstein SD; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Finlay JL; Sposto R;
Cancer Res; 2001 Oct; 61(20):7404-7. PubMed ID: 11606370
[TBL] [Abstract][Full Text] [Related]
20. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.
von Deimling A; Louis DN; Menon AG; von Ammon K; Petersen I; Ellison D; Wiestler OD; Seizinger BR
Acta Neuropathol; 1993; 86(1):81-5. PubMed ID: 8103960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
